Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px
Document › Details

Marinomed Biotech AG. (11/5/18). "Press Release: Marinomed Announces Its Intention to Launch an Initial Public Offering and Listing on the Vienna Stock Exchange [Not for US, AU, CA, JP, et al.]". Vienna.

Region Region Wien (Vienna)
  Country Austria
Organisations Organisation Marinomed Biotech AG (VSE: MARI)
  Organisation 2 Vienna Stock Exchange (VSE)
Products Product Marinosolv® technology platform
  Product 2 Carragelose®
Index term Index term Marinomed–SEVERAL: investment, 201811–201901 IPO €19.5m+€2.925m with 260k+39k new bearer shares at €75/share
Persons Person Grassauer, Andreas (Marinomed Biotechnologie GmbH 201307 CEO)
  Person 2 Schmidt, Pascal (Marinomed 201808– CFO before Raymond James Financial + Mummert & Co + Infineon Ventures)
     


   
Record changed: 2018-12-02

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria iito 273x168px

More documents for Marinomed Biotech AG (VSE: MARI)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna iito 600x60px




» top